Neoreviews
HOME HELP CONTACT US SUBSCRIPTIONS CME ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Take the CME quiz:
 Vol. 8 No. 12, December 2007
Right arrow E-Letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-Letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Adamkin, D. H.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Adamkin, D. H.

NeoReviews Vol.8 No.12 2007 e543
© 2007 American Academy of Pediatrics

Use of Intravenous Lipids in Very Low-birthweight Infants

David H. Adamkin, MD*

* Professor of Pediatrics, Director, Division of Neonatal Medicine, University of Louisville, Louisville, Ky

Lipids are essential components of parenteral nutrition for preterm infants to provide essential fatty acids and to meet high energy needs. However, there is concern about increased risks of sepsis, displacement of bilirubin from albumin, and pulmonary complications when parenteral lipids are provided to sick preterm infants early in postnatal life. Slow administration of intravenous lipid emulsions, with stepwise increases, appears to be well-tolerated in most preterm infants. High doses probably should be avoided in infants who have severe acute respiratory failure with or without pulmonary hypertension.






HOME HELP CONTACT US SUBSCRIPTIONS CME ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2007 by the American Academy of Pediatrics.